← Back to Search

ESPBs vs TAPs for Pain Relief After Breast Reconstruction Surgery

N/A
Recruiting
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult women with breast cancer, ASA 1-3, undergoing DIEP flap surgery
Be older than 18 years old
Must not have
Chronic opioid use contraindications to local anesthetics or regional analgesia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months post-operation
Awards & highlights
No Placebo-Only Group

Summary

This trial tests an alternative, less-invasive technique for pain relief after breast reconstruction surgery.

Who is the study for?
This trial is for adult women with breast cancer, who are in good to moderate health (ASA 1-3), and are scheduled for DIEP flap surgery. It's not open to those who regularly use opioids, have allergies to local anesthetics, or can't describe their pain level using a number scale.
What is being tested?
The study compares two types of pre-operative pain blocks: Erector Spinae Plane blocks (ESPBs) and Transversus Abdominus Plane blocks (TAPs). The goal is to see if ESPBs provide similar pain relief after breast reconstruction surgery as the commonly used TAPs do.
What are the potential side effects?
Potential side effects from both ESPBs and TAPs may include discomfort at the injection site, possible nerve damage, low blood pressure due to the anesthesia, and allergic reactions to the local anesthetic used.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman with breast cancer, in good to moderate health, getting DIEP flap surgery.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot use certain pain medications due to chronic opioid use or allergies.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months post-operation
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months post-operation for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Mean Morphine Equivalents
Michigan Body Map
Numerical Rating Scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Group 2: Transversus Abdominis Plane blocksExperimental Treatment1 Intervention
Transversus Abdominis Plane blocks
Group II: Group 1: Erector Spinae Plane blocksExperimental Treatment1 Intervention
Erector Spinae Plane blocks

Find a Location

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
517 Previous Clinical Trials
177,339 Total Patients Enrolled
2 Trials studying Pain
~54 spots leftby Jul 2026